To help you sort things out for Valentine's Day 2025, we have compiled a list of 10 gifting items that you can buy for your ...

Luckily for me (and you, if you’re in the same boat), lululemon’s viral Slouchy Sling bag ($68), which is the ideal everyday ...

Manufacturer description: The unique 3N1-22 DL bag provides three carrying options in one, morphing from right sling to backpack to left sling. Changing carrying positions is fast and easy by use of ...

With the rise of the ready-for-anything, giant tote, and the recent popularity of a Birkin dupe, we look at the evolution of the It bag and ask what our choice of bag reveals. If you're the sort ...

Want to watch the playoff game online? NBC is a network available via Sling Blue. Additionally, the streamer’s Sling Blue features nearly 50 other channels, like Bravo, Discovery Channel ...

The pants, which look eerily similar to a designer version for more than nine times the price, are offered in four colorways (medium gray heather, black soot, grayed teal, and wild mushroom).

This shift has been bubbling since at least spring of last year, and now, it’s official: welcome to the resurgence of big bags—or, at least, bags bigger than a lipstick and a credit card.

The two came together in 2020 and launched Teal Heath, a company sharing resources about women’s health and looking to create products so women can conduct cervical cancer screenings at home.

Perfect for work commutes or lunch meetings, this tote bag combines functionality and style, ensuring you carry your items with ease and sophistication. The Accessorize London Women's Faux Leather ...

Sling TV is trying to do just that with its cloud DVR, which has removed its previous recording limits and is now “unlimited.” “Unlimited DVR (previously called DVR Plus) will allow ...

The new interface for DIsh Network’s streaming TV service Sling TV. (Graphic by The Desk) Echostar-owned streaming television service Sling TV has debuted an unlimited cloud DVR feature that allows ...

Sling Therapeutics’ oral challenger to Amgen’s intravenous Tepezza has hit the mark in a phase 2b/3 thyroid eye disease (TED) trial, teeing the biotech up to run a confirmatory study of its ex ...